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Abstract
Background: The complications of reversed total shoulder arthroplasty (RTSA) requiring an additional intervention,
their treatment options and outcome are poorly known. It was therefore the purpose of this retrospective study, to
identify the reasons for revision of RTSA and to report outcomes.
Methods: Four hundred and forty-one performed RTSA implanted between 1999 and 2008 were screened. Sixty-
seven of these cases had an additional intervention to treat a complication. Causes were identified in these 67
cases and the outcome of the first 37 patients who could be followed for more than two years after their first
additional intervention was analyzed.
Results: Of 441 RTSA, 67 cases (15%) needed at least one additional intervention to treat a complication, 30 of
them needed a second, eleven a third and four a fourth additional intervention. The most common complication
requiring a first intervention was instability (18%) followed by hematoma or superficial wound complications (15%)
and complications of the glenoid component (12%). Patients benefitted from RTSA despite the need of additional
interventions as indicated by a mean increase in total Constant-Murley score from 23 points before RTSA to 46
points at final follow-up (p < 0.0001).
Conclusions: Instability, hematoma or superficial wound complications and complications of the glenoid
component are the most common reasons for an additional intervention after RTSA. Patients undergoing an
additional intervention as treatment of these complications profit significantly as long as the prosthesis remains in
place.
Background
Reverse total shoulder arthroplasties (RTSA) has become
a valuable treatment option for irreparable rotator cuff
failure [1-6], associated or not with osteoarthritis or pros-
thetic humeral replacement. The reversal of the physio-
logical ball and socket configuration of the humerus and
glenoid has become a clinically successful concept which,
however, changes joint physiology and biomechanics
[2,7] and bears the potential for complications which
have been reported to be more frequent than those of
conventional total shoulder replacement. Complications
reported to be frequent are scapular notching, infection,
instability, acromial fractures, hematoma formation and
complications of the glenoid component [2,8-17]. The
frequency of these complications has been described
with variable accuracy of reporting and heterogeneity of
methodology between the studies [18]. There is lack of
information about clinical implications of at least some
of these complications about treatment and eventual
outcomes.
It was therefore the purpose of this retrospective study
to identify and analyze the reasons for additional inter-
ventions needed for treatment of complications after
RTSA and to report outcomes.
Methods
Approval for retrospective analysis of data used in this
study was given by the state ethical committee of Zürich,
Switzerland. The institutional registry for shoulder and
elbow prosthesis was screened to identify 480 consecu-
tively implanted RTSA (232 Delta III™, Depuy and 248
Anatomical Reverse™, Zimmer) implanted between 1999
and 2008. Of those, 39 were either implantation of com-
ponents of RTSA or complete RTSAs for prosthetic revi-
sions leaving 441 RTSAs implanted for reasons other
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than prosthetic revision. A total of 96 patients with revi-
sion after RTSA were identified. Of those, the primary
RTSA was performed in our institution in 67 patients
(Revision rate = 15%) and 29 patients had been referred
for treatment of complications after RTSA. Those 29
were excluded from further analysis due to lack of pri-
mary data and potential heterogeneity of implantation
and postoperative treatment regimens. Fifty-five of the
67 patients had a minimum follow-up of two years fol-
lowing RTSA. Thirty-seven of the 55 patients had a
minimum follow-up of two years after their first revi-
sion. The charts including all operative protocols of all
67 cases were retrospectively analyzed to identify basic
patients demographics, the number and type of add-
itional interventions performed in each patient, reasons
for each additional intervention and the performed pro-
cedure for all included patients. For assessment of out-
come, the 37 patients with a follow-up of more than
2 years after the additional intervention were contacted
and the clinical outcome, including physical and radio-
graphic examination and assessment of Subjective
Shoulder Value (SSV) and Constant-Murley score [19]
could be obtained in 31 patients. Six patients could not
be personally reviewed and the Constant-Murley score
could not be documented at follow-up: two patients had
died from unrelated causes, one patient had pursued
treatment in another institution and three patients could
not be reviewed because two institutionalized for de-
mentia were unable to respond and one could not be
traced. A subgroup was formed to analyze patients out-
comes with the most common indications for an add-
itional intervention, namely instability.
Statistical analysis
Data were statistically tested for normal distribution
using the D’Agostino and Pearson omnibus normality
test before applying either two tailed paired Students-t-
test or Wilcoxon test for normally and not-normally dis-
tributed data for intra-sample comparison. Values are
reported as mean and standard deviations or 95% confi-
dence interval where appropriate. All statistical tests
were performed using a commercial statistical software
package, with significance levels set at p < 0.05.
Results
Reasons for revision after RTSA
Baseline characteristics are summarized in Table 1.
Sixty-seven patients with a mean age of 69 ± 9 years
(male to female ratio of 0.5 to 1) needed at least one
additional intervention to treat a complication of RTSA,
thirty of them needed a second, eleven a third and four
a forth intervention. Additional interventions after RTSA
were needed at between the same day of the RTSA and
eight years thereafter, with a mean of 17 months
postoperatively. Overall, the most common reason for
the first intervention was instability resulting in sublux-
ation or dislocation (n = 12, (18%)) occurring at a mean
of 17 months after initial RTSA (5 days to 72 months).
However this complication was seen in 11 of 44
shoulders with Delta-III prostheses and in 1 of 23
patients with Anatomical Reverse prostheses (significant
difference with confidence of >90% by a two tailed z-test
of proportions). It was definitely treated by closed reduc-
tion in those five cases if no further component re-
dislocation was radiologically evident and no recurrent
subluxation was reported. A change of components of
the prosthesis was necessary in seven cases: Selection of
a higher humeral polyethylene inlay was used in three,
revision of a glenoid component in two and revision of a
humeral component in two cases. The second most
common reasons for revision were hematoma and
superficial wound problems (e.g. dehiscence) (n = 10,
(15%)) occurring after a mean of 38 days. Hematoma
was treated by simple evacuation in seven cases. Other
frequent reasons for revision were complications of the
glenoid component (n = 8, (12%)) and acromial (n = 5) or
coracoid fractures (n = 2, (10%)). Complications of the
glenoid component were treated in four cases by change
of the glenoid (1 Delta and 3 Anatomical) component
and in three cases by conversion (1 Delta and 2 Anatom-
ical) to a hemi-prosthesis. In one case infection was sus-
pected and a spacer was implanted (Table 2). Infections,
deficiency in external rotation, acromio-clavicular path-
ologies and humeral component loosening were followed
by other infrequent reasons such as wear of compo-
nents, metallosis and other rare events (Table 3). The
two most common reasons for a second intervention
were instability (n = 7, 23% of all reasons for the second
intervention) and infections (n = 6, 20%). The most com-
mon reason for the third (n = 5, 45%) and forth (n = 2,
50%) intervention was again instability.
Table 1 Basic characteristics and indication for primary
RTSA in 67 patients with revisions after RTSA
Basic charactersitics Total
(n = 67)
Delta III
(n = 44)
Anatomical
Reverse (n = 23)
age 69 ± 9 years 69 ± 9 years 69 ± 10 years
male : female 23 : 44 16:28 7:16
right : left 39 : 28 27:17 12:11
dominant arm 42 of 67 27 of 44 15 of 23
Indications for
primary RTSA
RCR and OA 24 16 8
Irreparable RCR 17 13 4
Failed hemiarthroplasty 16 9 7
Sequels of fracture 10 6 4
RCR: Rotator cuff rupture, OA: Osteoarthritis.
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Outcome after revision of RTSA
Thirty-seven patients could be reviewed at no less than
two years with a mean follow-up of 47 (range 24 to 150)
months after the first revision. Twenty-one of these 37
patients needed a second, nine a third and four a forth
additional intervention to treat complications associated
with RTSA. The most common cause for an re-
intervention in these 37 patients was similar to the total
cohort of 67 patients. Instability (n = 9, (24%)) was the
most common reason for an intervention followed by
hematoma or superficial wound complications (n = 6,
(16%)) and complications of the glenoid component
(n = 3, (8%)). However, an external rotation deficit per-
ceived as disabling and correctable was also a relevant
reason for revision in this subgroup (n = 5, (14%)). The
most common indication of an additional intervention
consistently was instability in the second (n = 5, (24% of
all revision causes)), third (n = 4, (44%)) and forth add-
itional intervention (n = 2, 50%)). The total Constant-
Murley score of the 31 personally examined patients
increased by 24 points (95% CI: 17, 31) (p < 0.0001) from
the time-point immediately before implantation of the
RTSA to the last follow-up at an mean of 49 months
(95% CI: 1382, 1777 days) after RTSA. There was a sig-
nificant increase in SSV, relative Constant-Murley score,
abduction strength and a substantial decrease in pain
(Table 4). There was an increase in ability to abduct the
arm, but a loss of active internal rotation (Table 4).
Instability and treatment procedure
The indication for the first closed or open revision was
instability with twelve of 67 cases. These twelve patients
Table 2 Complications of the glenoid component as reason for the first re-intervention after RTSA
Primary Indication for RTSA Complication leading to re-intervention Treatment of the complications
(n=) (n=) (n=)
Anatomical Reverse Irreparable RCR (2) Glenoid loosening (2) Glenoid change (2)
Irreparable RCR and OA (3) Pullouts (3) Conversions to hemi-TP (2)
Spacer implantation (1)
Delta III Irreparable RCR (1) Glenoid loosening (1) Glenoid change (2)
Failed of hemi-prosthesis (1) Pullout (1) Conversion to hemi-prosthesis (1)
Sequel of fracture (1) Glenosphere disassembly (1)
RCR: Rotator cuff rupture, OA: Osteoarthritis.
Table 3 Reasons for the first re-intervention after RTSA
Total Delta III Anatomical Reverse
(n = 67) % (n = 44) % (n = 23) %
Instability* 12 17.9 11 25.0 1 4.3
Wound dehiscence/ hematoma 10 14.9 8 18.2 2 8.7
Complications of the glenoid component 8 11.9 3 6.8 5 21.7
Acromial or coracoid fracture 7 10.4 5 11.4 2 8.7
Pain* 6 8.9 1 2.3 5 21.7
Deficient external rotation 5 7.5 2 4.5 3 13.0
Infection 3 4.5 3 6.8 0 0.0
Humeral component loosening 3 4.5 3 6.8 0 0.0
Disturbing ORIF material 2 3.0 2 4.5 0 0.0
Periprosthetic fracture 2 3.0 2 4.5 0 0.0
Dislocation of greater tuberosity 2 3.0 1 2.3 1 4.3
Component wear 2 3.0 2 4.5 0 0.0
Deficient internal rotation 1 1.5 0 0.0 1 4.3
Subacromial impingement 1 1.5 0 0.0 1 4.3
Heterotopic ossification 1 1.5 1 2.3 0 0.0
Metallosis (inferior screw notching) 1 1.5 0 0.0 1 4.3
Humeral component subsidence 1 1.5 0 0.0 1 4.3
*Significantly different (Delta-III vs. Anatomical Reverse).
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did not differ from the entire cohort of 67 patients with
regard to age (70 ± 7 years vs 69 ± 9 years) or gender
(male to female: 0.5 to 1 in both groups) but to the type
of prosthesis used for primary RTSA (Delta to Anatom-
ical: 11:1 compared to 44:23). Early occurrence of in-
stability (mean 101 days) was treated by closed reduction
under general anesthesia (n = 5), later occurrence of in-
stability (mean 781 days) was treated operatively (n = 7).
From those five patients who were treated with closed re-
duction initially, in two patients a second intervention
was performed subsequently; one was treated with
change of the inlay (two days after reposition) and the
other patient needed a closed reduction one day after ini-
tial reposition and a change of the humeral component
was performed 3 weeks after.
In the other seven patients in whom instability occurred
later, lengthening the prosthesis using a thicker inlay was
performed in three cases, a change of the glenoid compo-
nent in two and exchange of the humeral component in
other two cases. One patient in whom the glenoid com-
ponent was changed needed a second revision with
change of the humeral component 25 days after. This was
also the case in one of the patients with initial change of
inlay who also needed a third intervention (conversion to
a Hemi-prosthesis, 27 days later) followed by removal of
the prosthesis (172 days after conversion) because of a
chronic subluxation with compression of the brachial
plexus and denial of the patient to undergo arthrodesis.
Another patient also with initial change of inlay showed
recurrent dislocation treated by closed reduction 91 days
after followed by change of the prosthesis 171 days after.
One of the two patients who were revised because of a
dislocation that could not be reduced closed, was treated
with an exchange of the stem including correction of
version. She developed an incomplete plexus palsy two
days postoperatively which was attributed to tension,
was treated conservatively with a splint maintaining the
arm in flexion and recovered only partially.
Infection and treatment procedure
In the cohort of 67 patients with 112 revisions, the total
amount of indication for a revision was infection in ten
cases, from which three were first revisions, six were sec-
ond revisions and one third revision. Patients with infec-
tions were treated mostly with implantation of a spacer
(n = 6) or with either debridement (n = 2) or total explan-
tations of the prosthesis (n = 2). One of the patients was
revised two times for infection. The most common patho-
gen was Propionibacterium acnes (n = 4). Broad antibiotic
therapy was initiated intraoperatively and was replaced by
antibiotics specific to the pathogen once results of bac-
teriological analyses were available and continued during
a mean of 4 months (range 45 to 360 days). One of the
patients with total explantation of the prosthesis died of
an unrelated reason before 24 months follow-up after ex-
plantation. The outcome was not different in patients
with revision for infection if compared with the whole co-
hort of 31 fully followed patients. The total Constant-
Murley score of patients revised for infection increased
also by 23 points (95% CI: 10.2, 37.6) from the time before
RTSA to final follow-up as did the relative Constant-
Murley score with a gain of 32% (95% CI: 24.7, 50.2) from
a baseline that was very similar to the whole cohort
(Table 4). In six cases there were no sings of a recurrent
infection, in three cases the patients are still with an anti-
biotic spacer and do not wish to undergo re-implantation
of a RTSA and one patient died of an unrelated cause
with a resection arthroplasty for treatment of infection.
With the data available, we were unable to identify
specific risk factors for infection in our material, specif-
ically superficial hematoma and wound dehiscence were
surprisingly not associated with a statistically higher in-
fection rate.
Discussion
Complications after RTSA are more common than after
conventional total shoulder arthroplasty. The studies
Table 4 Clinical outcome of patients with a minimal follow-up of 2 years after the first re-intervention (n= 31) after
RTSA
Before RTSA Last follow-up
mean (95% CI) mean (95% CI)
Total Constant-Murley score 23 (17.8, 27.2) 46 (38.0, 53.8) p < 0.0001
Relative Constant-Murley score (%) 30 (23.9, 36.8) 62 (51.8, 73.0) p < 0.0001
Subjective Shoulder Value (%) 18 (11.2, 24.2) 49 (39.9, 57.2) p < 0.0001
Pain (points as in Constant-Murley score) 5.4 (3.87, 6.9) 11 (9.4, 12.7) p < 0.0001
Abduction strength (kg) 0.29 (0, 0.63) 1.9 (0.97, 2.82) p < 0.001
Range of motion:
Abduction (°) 49 (35.9, 62.1) 97 (81.1, 112.8) p < 0.0001
Internal rotation (°) 41 (29.9, 52) 14 (3.9, 24.8) p < 0.001
External rotation (°) 5.5 (−5.0, 16.0) 10.8 (0.6, 21.0) p = 0.2757
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reporting these complications are heterogeneous in their
methodology making a ranking of the most to the least
common complication difficult [18]. More importantly,
information about the relevance of the complications
with regard to necessity for revision, as well as to the
outcome after revision is sparse. The current study is
retrospective and has therefore to be interpreted with
caution. From a methodological point of view however, a
prospective design for investigation of the relatively rare
event of revision needed after RTSA would demand high
resources and most probably a multicenter design. For
the interpretation of the current data, incomplete docu-
mentation with inordinately high loss of follow-up might
be a major problem. Lack of documentation was present
in this study but only in the personal follow-up of 6 of
the 37 patients. They had been reviewed clinically and
radiographically in clinic at more than 24 months after
their first revision but they were not scored according to
Constant and Murley at that period of time. There were,
however, no findings in the charts suggesting, that the
scores or radiographic outcomes of these six patients
would be markedly different from those of the other 31
patients. Another challenge for data interpretation was
the multiplicity of indications for revision that could not
be addressed by subgroup analysis because of the sample
size.
The focus of this study was on the indications for
RTSA revision in one specific department with a rela-
tively large experience with RTSA rather than on an
enumeration of the frequently discussed complications.
In this respect, it is interesting that only one of 67
patients was revised because of inferior notching with
contact of the inferior screw with the humeral compo-
nent which had caused metallosis and pain but not loos-
ening. Conversely there were other reasons that led not
surprisingly to an overall high revision rate of 15% for
RTSA. The cohort of the patients needing revision after
RTSA consisted almost exclusively of those in whom
RTSA has been implanted for salvaging situations not
amenable to any alternative treatment and involving
100% of shoulders with previous operations (mean of
2 ± 1.4 operations). The revision rate of 15% documented
in our cohort is inline with a recent report by Fevang
et al.[20] of 36 revision needed for 225 RTSA (revision
rate of 16%), in which the most common reason for revi-
sion after RTSA was identified to be aseptic loosening of
the glenoid component followed by instability and dis-
location. We identified instability as the most common
reason for re-intervention after RTSA. This might be
caused by the different indications of RTSA; the cohort
investigated by Fevang et al.[20] consisted mainly of
patients with inflammatory arthritis while the indication
of RTSA in our cohort was mainly an irreparable
massive rotator cuff with or without osteoarthritis.
We had started to use the Delta III reverse system in
1996 on a regular basis and changed to another system
in 2005. For this study we attempted to eliminate the
early phase of our learning curve and started our review
with RTSAs which had been implanted no earlier than
1999. The overall revision rate was double as high with
the first than with the second reverse system that we
used. Although this difference is statistically significant
we feel that it is mostly reflection of the fact that our
knowledge, understanding and practical experience
increased still substantially after 1999.
The most frequent indication for a re-intervention was
instability and this for the first, the second and subse-
quent revisions. Almost all our operations were per-
formed through a deltopectoral approach which has
been identified as a risk factor for instability as com-
pared with the superolateral approach [8]. For this prob-
lem, revision triggers have not changed during the study
period, but the significantly lower revision rate with the
second prosthetic design utilized may be related to bet-
ter surgical technique and differences in indication. We
cannot disagree but also not statistically affirm that early
redislocation [8] can not be successfully treated with
closed reduction alone and is probably a problem of
component positioning including height of the pros-
thesis [21].
Hematoma and wound dehiscence have previously
been identified as an inordinately frequent complication
in our environment [12]. We currently still use two suc-
tion drains postoperatively for 48 hours in RTSA to
drain the large subacromial space and have reduced
postoperative hematoma and wound complications dras-
tically. In revision surgery we will in addition to careful
surgical hemostasis also use fibrin sealants to try to
avoid hematoma formation and thereby the need for as-
piration or revision. We feel that this complication is a
truly surgical complication not in relation with the type
of reverse implant utilized.
The 31 patients with a minimum follow-up of two years
after the first revision who had undergone a mean of 1.8
revisions approximately doubled their Constant-Murley
score from the time before RTSA to final follows-up. This
was seen also in patients where the reason for revision
was an infection. Although the range of motion increased
in abduction and remained nearly the same in external
rotation, it did not improve internal rotation. This obser-
vation has been described to be associated with RTSA [1]
and not specific to patients with revision.
Except for instability, there were no relevant differ-
ences between the two prosthetic systems studied. The
fact that the revision rate of the second system used was
substantially lower was attributed to the increased know-
ledge concerning indication and increased skill in exe-
cuting RTSA and may reflect the benefit of surgical
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experience in RTSA more so [22] than selecting one or
the other system.
Conclusions
Instability, hematoma or superficial wound complica-
tions and complications of the glenoid component are
the most common reasons for an additional intervention
after RTSA. Patients undergoing a revision as treatment
of these complications profit significantly as long as the
prosthesis remains in place.
Competing interests
The senior author (GC) has received royalties from Zimmer Inc. The other
authors did not receive anything of value from or own stock in a
commercial company or institution related directly to the subject of this
article.
Authors’ contributions
All authors have made substantial contributions to this study; MF was
involved in conception and design and analysis and interpretation of data
and in drafting the manuscript. MG and SC were involved in the acquisition
of data, interpretation of data and revising the manuscript critically for
important intellectual content. GC was involved in conception and design of
the study and interpretation of data, revising the manuscript critically for
important intellectual content and supervision and coordination of the
research group. All authors read and approved the final manuscript.
Received: 24 September 2011 Accepted: 21 August 2012
Published: 27 August 2012
References
1. Boileau P, Gonzalez JF, Chuinard C, Bicknell R, Walch G: Reverse total
shoulder arthroplasty after failed rotator cuff surgery. J Shoulder Elbow
Surg 2009, 18(4):600–606.
2. Boileau P, Watkinson DJ, Hatzidakis AM, Balg F: Grammont reverse
prosthesis: design, rationale, and biomechanics. J Shoulder Elbow Surg
2005, 14(1 Suppl S):147S–161S.
3. Boulahia A, Edwards TB, Walch G, Baratta RV: Early results of a reverse
design prosthesis in the treatment of arthritis of the shoulder in elderly
patients with a large rotator cuff tear. Orthopedics 2002, 25(2):129–133.
4. Cuff D, Pupello D, Virani N, Levy J, Frankle M: Reverse shoulder
arthroplasty for the treatment of rotator cuff deficiency. J Bone Joint Surg
Am 2008, 90(6):1244–1251.
5. Gerber C, Pennington SD, Nyffeler RW: Reverse total shoulder arthroplasty.
J Am Acad Orthop Surg 2009, 17(5):284–295.
6. Vanhove B, Beugnies A: Grammont's reverse shoulder prosthesis for
rotator cuff arthropathy. A retrospective study of 32 cases. Acta Orthop
Belg 2004, 70(3):219–225.
7. Kontaxis A, Johnson GR: The biomechanics of reverse anatomy shoulder
replacement--a modelling study. Clin Biomech (Bristol, Avon) 2009,
24(3):254–260.
8. Mole D, Favard L: Excentered scapulohumeral osteoarthritis. Rev Chir
Orthop Reparatrice Appar Mot 2007, 93(6 Suppl):37–94.
9. Levy J, Frankle M, Mighell M, Pupello D: The use of the reverse shoulder
prosthesis for the treatment of failed hemiarthroplasty for proximal
humeral fracture. J Bone Joint Surg Am 2007, 89(2):292–300.
10. Levy JC, Virani N, Pupello D, Frankle M: Use of the reverse shoulder
prosthesis for the treatment of failed hemiarthroplasty in patients with
glenohumeral arthritis and rotator cuff deficiency. J Bone Joint Surg Br
2007, 89(2):189–195.
11. Guery J, Favard L, Sirveaux F, Oudet D, Mole D, Walch G: Reverse total
shoulder arthroplasty Survivorship analysis of eighty replacements
followed for five to ten years. J Bone Joint Surg Am 2006, 88(8):1742–1747.
12. Werner CM, Steinmann PA, Gilbart M, Gerber C: Treatment of painful
pseudoparesis due to irreparable rotator cuff dysfunction with the Delta
III reverse-ball-and-socket total shoulder prosthesis. J Bone Joint Surg Am
2005, 87(7):1476–1486.
13. Frankle M, Siegal S, Pupello D, Saleem A, Mighell M, Vasey M: The Reverse
Shoulder Prosthesis for glenohumeral arthritis associated with severe
rotator cuff deficiency A minimum two-year follow-up study of sixty
patients. J Bone Joint Surg Am 2005, 87(8):1697–1705.
14. Klein M, Juschka M, Hinkenjann B, Scherger B, Ostermann PA: Treatment of
comminuted fractures of the proximal humerus in elderly patients with
the Delta III reverse shoulder prosthesis. J Orthop Trauma 2008,
22(10):698–704.
15. Grassi FA, Murena L, Valli F, Alberio R: Six-year experience with the Delta III
reverse shoulder prosthesis. J Orthop Surg (Hong Kong) 2009,
17(2):151–156.
16. Sirveaux F, Favard L, Oudet D, Huquet D, Walch G, Mole D: Grammont
inverted total shoulder arthroplasty in the treatment of glenohumeral
osteoarthritis with massive rupture of the cuff. Results of a multicentre
study of 80 shoulders. J Bone Joint Surg Br 2004, 86(3):388–395.
17. Wierks C, Skolasky RL, Ji JH, McFarland EG: Reverse total shoulder
replacement: intraoperative and early postoperative complications. Clin
Orthop Relat Res 2009, 467(1):225–234.
18. Farshad M, Gerber C: Reverse total shoulder arthroplasty-from the most
to the least common complication. Int Orthop 2010, 34(8):1075–1082.
19. Constant CR, Gerber C, Emery RJ, Sojbjerg JO, Gohlke F, Boileau P: A review
of the Constant score: modifications and guidelines for its use. J Shoulder
Elbow Surg 2008, 17(2):355–361.
20. Fevang BT, Lie SA, Havelin LI, Skredderstuen A, Furnes O: Risk factors for
revision after shoulder arthroplasty: 1,825 shoulder arthroplasties from
the Norwegian Arthroplasty Register. Acta Orthop 2009, 80(1):83–91.
21. Ladermann A, Williams MD, Melis B, Hoffmeyer P, Walch G: Objective
evaluation of lengthening in reverse shoulder arthroplasty. J Shoulder
Elbow Surg 2009, 18(4):588–595.
22. Walch G, Bacle G, Ladermann A, Nove-Josserand L, Smithers CJ: Do the
indications, results, and complications of reverse shoulder arthroplasty
change with surgeon's experience? J Shoulder Elbow Surg 2012, Epub
ahead of print.
doi:10.1186/1471-2474-13-160
Cite this article as: Farshad et al.: Revision of reversed total shoulder
arthroplasty. Indications and outcome. BMC Musculoskeletal Disorders
2012 13:160.
Submit your next manuscript to BioMed Central
and take full advantage of: 
• Convenient online submission
• Thorough peer review
• No space constraints or color ﬁgure charges
• Immediate publication on acceptance
• Inclusion in PubMed, CAS, Scopus and Google Scholar
• Research which is freely available for redistribution
Submit your manuscript at 
www.biomedcentral.com/submit
Farshad et al. BMC Musculoskeletal Disorders 2012, 13:160 Page 6 of 6
http://www.biomedcentral.com/1471-2474/13/160
